DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. It is illegal to introduce this substance into the body. Only licensed professionals should handle it. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.
CJC-1295 (No DAC) + Ipamorelin + GHRP-2+ Sermorelin (Blend)
CJC-1295 (no DAC), Sermorelin, Ipamorelin, and GHRP-2 are studied together to maximize growth hormone release by stimulating both GHRH and ghrelin pathways through complementary mechanisms.
Quantity: 1
All peptides arrive in powdered form for stability
What is CJC-1295 (No DAC) + Ipamorelin + GHRP-2+ Sermorelin (Blend)?
CJC-1295 without Drug Affinity Complex (no DAC) is a short-acting analog of growth hormone–releasing hormone (GHRH) that promotes natural GH release in a physiologic pulse pattern. Sermorelin is another synthetic GHRH analog with a shorter amino acid chain (29 amino acids) that also stimulates the pituitary to release GH. Ipamorelin is a selective growth hormone secretagogue (GHS) that activates ghrelin receptors to enhance GH secretion without significantly affecting cortisol or prolactin. GHRP-2 is a potent hexapeptide GHS that targets the same ghrelin receptor but with stronger GH-releasing potency than GHRP-6. In research settings, this combination is explored for potentially maximizing GH output by activating multiple hormonal pathways.
Potential Benefits Shown in Studies
Possible benefits of CJC‑1295 (no DAC) + Sermorelin + Ipamorelin + GHRP‑2 Blend:
- Maximized GH Release
- Improved Muscle Growth & Recovery
- Optimized Fat Metabolism & Body Composition
- Keeps Natural Hormone Rhythm
- Clean Hormonal Profile
- Safe, Feedback-Regulated Action
Mechanisms of Action
CJC-1295 (no DAC) + Ipamorelin + Sermorelin + GHRP-2 may work together by:
- CJC-1295 (no DAC): Binding to GHRH receptors for short bursts of GH release that mimic natural secretion cycles
- Sermorelin: Stimulating GHRH receptors with a shorter-acting profile, potentially increasing pulse frequency
- Ipamorelin: Selectively activating ghrelin receptors for clean GH release without unwanted hormone spikes
- GHRP-2: Strongly activating ghrelin receptors for higher GH pulse amplitude compared to other GHRPs
- Increasing circulating IGF-1 to support protein synthesis, tissue repair, collagen production, and metabolism
- Enhancing recovery, connective tissue health, and fat metabolism in research models
CJC-1295 (No DAC) + Ipamorelin + GHRP-2+ Sermorelin (Blend) Research Highlights
Research and supplier summaries note that using CJC‑1295, Ipamorelin, and GHRP‑2 together enhances GH output more than any single peptide alone.
Source: heall
Combining CJC‑1295 (no DAC) with Ipamorelin has been shown to raise both the amplitude and frequency of growth hormone release—supporting dynamic pulsatility while preserving feedback control.
Source: peptideres
Studies and comparative reviews report this peptide stack supports lean muscle and metabolic enhancement by optimizing GH target engagement.
Source: tydes